Flagship Pioneering has launched Lila Sciences, a company at the forefront of scientific innovation, aiming to revolutionize the way experiments are conducted in life, chemical, and materials sciences. Lila's unique superintelligence platform leverages advanced AI to not only analyze data and predict outcomes but also design and execute experiments autonomously, generate hypotheses, and conduct real-world tests. The company has secured $200 million in seed funding from investors like Flagship Pioneering, General Catalyst, and more. By combining generative AI with autonomous science units, Lila has made strides in various fields, surpassing existing therapeutics in genetic medicine design, discovering new biological compounds, and contributing to the development of advanced materials for green hydrogen production and carbon capture. Led by a team of experts including Geoffrey von Maltzahn, Molly Gibson, and George Church, Lila aims to collaborate with industry partners to expedite scientific advancements in health and sustainability. Flagship Pioneering's CEO, Noubar Afeyan, emphasized the potential of Lila to unlock hidden discoveries through scaled experimentation, ultimately benefiting society with accelerated scientific progress.